Triple Combination Chemotherapy Effective For Advanced Colorectal Cancer, Trial Finds
Drug Cleared For GIST And Kidney Cancer, FDA’s First Two-Indication Cancer Approval
Liver Transplants Extend Survival In Early-Stage Cancer
Trimodality Therapy Improves Survival In Early Disease
NCI Encourages IP Chemo For Stage III Ovarian Cancer
Study Finds No Evidence That Statins Cut Cancer Risk
Chest X-Ray Produces Many False-Positive Results
NMP22 Assay More Effective Than Conventional Lab Test
Chemotherapy After Surgery Extends Survival By 32%
Some Tumors Show Partial Response To Drug Combo
Recombinant TSH Avoids Need To Stop Replacement Therapy
Partial Responses To Zactima In Thyroid Cancer Trial
NCI-Approved Clinical Trials
Trending Stories
- Pam Bondi diagnosed with thyroid cancer
- Kennedy calls for a “moonshot” targeted on the role of the microbiome in cancer
- Daraxonrasib’s success in treating pancreatic cancer is a reminder that clinical cancer researchers are heroes
- As FDA’s wheels almost entirely come off, NCI remains sturdy—a cancer moonshot may even be on the horizon
- UK Markey’s Denise Fabian: Theranostics lets us pair a diagnostic with a radioactive therapeutic that target the same molecule
- When CAM is added to standard therapies, survival rates drop, observational study finds
